India prevention Research Beyond Barrett Акции DISH Компании India

The 12p health supplement that could help prevent and reverse type 2 diabetes

Reading now: 219
www.dailyrecord.co.uk

Health gurus have highlighted a specific herb that could potentially reverse or prevent type 2 diabetes, and it's also very affordable to buy.

Research has shown that fenugreek can have a positive impact on blood sugar and cholesterol levels.Fenugreek, available in pill form from retailers such as Holland and Barrett, is an affordable addition to your health regime.

A tub of 90 capsules retails for £10.99, working out at just 12p per tablet.The leaves and seeds of fenugreek are versatile, adding a unique flavour to curries and other dishes, making it a staple in many Asian recipes.

Beyond its culinary uses, fenugreek is also recognised for its medicinal properties.Fenugreek seeds, scientifically known as trigonella foenum graecum, are rich in soluble fibre.

Read more on dailyrecord.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Susan Hopkins - COVID-19 variants identified in the UK – latest updates - gov.uk - Britain - city Oxford
gov.uk
46%
922
COVID-19 variants identified in the UK – latest updates
UKHSA) has published its containing updated analysis of the emergent variant BA.2.86.BA.2.86 continues to transmit within the UK, with sporadic cases identified in most regions.The briefing contains early laboratory data from a number of scientific organisations around the UK, including UKHSA’s own Vaccine Development and Evaluation Centre (VDEC), the University of Oxford, the Glasgow Centre of Virus Research and the Pirbright Institute.This early data indicates that BA.2.86 is no more likely to evade existing antibodies than XBB.1.5, another variant that has been circulating widely in the UK.While the available data remains limited, there is currently no evidence to suggest that BA.2.86 infection is more likely to make people seriously ill than currently-circulating variants, while vaccination is likely to provide continued protection.UKHSA will continue to monitor vaccine effectiveness in the population throughout the winter and will publish updated analysis in due course.Professor Susan Hopkins, Chief Medical Advisor, UKHSA said:While this is still very early data and more research is needed before we can be certain, it is encouraging to see an initial indication that BA.2.86 demonstrates similar levels of antibody escape compared to other variants circulating in the UK. The available data is too limited to draw conclusions about the severity of the illness it causes, but there is so far no evidence to suggest that it is more likely to make people seriously ill than other Omicron variants in circulation.The autumn vaccination programme started this month, and this new data shows once again how important it is that the most vulnerable among us are fully vaccinated in order to receive the greatest possible protection.
DMCA